Feature Ascentage reviving programmed cell death with novel approach to hematologic malignancies Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) is advancing its proprietary drug discovery platform of first- and best-in-class small molecule therapies to address unmet medical needs in cancers and other diseases. August 12, 2025